These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30151986)

  • 1. Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.
    Elzembely MM; Dahlberg AE; Pinto N; Leger KJ; Chow EJ; Park JR; Carpenter PA; Baker KS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27421. PubMed ID: 30151986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma.
    Qayed M; Chiang KY; Ricketts R; Alazraki A; Tahvildari A; Haight A; George B; Esiashvili N; Katzenstein HM
    Pediatr Blood Cancer; 2012 Mar; 58(3):448-52. PubMed ID: 21538822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
    Haghiri S; Fayech C; Mansouri I; Dufour C; Pasqualini C; Bolle S; Rivollet S; Dumas A; Boumaraf A; Belhout A; Journy N; Souchard V; Vu-Bezin G; Veres C; Haddy N; De Vathaire F; Valteau-Couanet D; Fresneau B
    Bone Marrow Transplant; 2021 Aug; 56(8):1984-1997. PubMed ID: 33824435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems.
    Cohen LE; Gordon JH; Popovsky EY; Gunawardene S; Duffey-Lind E; Lehmann LE; Diller LR
    Bone Marrow Transplant; 2014 Apr; 49(4):502-8. PubMed ID: 24442245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.
    Elzembely MM; Park JR; Riad KF; Sayed HA; Pinto N; Carpenter PA; Baker KS; El-Haddad A
    J Glob Oncol; 2018 Sep; 4():1-12. PubMed ID: 30241255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants.
    Armstrong AE; Danner-Koptik K; Golden S; Schneiderman J; Kletzel M; Reichek J; Gosiengfiao Y
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):31-35. PubMed ID: 28538090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
    Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Wolf J; Nyström M; Hovi L
    Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of high-dose
    Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
    J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
    Park JR; Kreissman SG; London WB; Naranjo A; Cohn SL; Hogarty MD; Tenney SC; Haas-Kogan D; Shaw PJ; Kraveka JM; Roberts SS; Geiger JD; Doski JJ; Voss SD; Maris JM; Grupp SA; Diller L
    JAMA; 2019 Aug; 322(8):746-755. PubMed ID: 31454045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications in survivors of advanced stage neuroblastoma.
    Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
    Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.
    Granger M; Grupp SA; Kletzel M; Kretschmar C; Naranjo A; London WB; Diller L
    Pediatr Blood Cancer; 2012 Nov; 59(5):902-7. PubMed ID: 22744917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database.
    Desai AV; Li Y; Getz K; Seif AE; Fisher B; Huang V; Aplenc R; Bagatell R
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27372. PubMed ID: 30070014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party.
    Philip T; Ladenstein R; Lasset C; Hartmann O; Zucker JM; Pinkerton R; Pearson AD; Klingebiel T; Garaventa A; Kremens B; Bernard JL; Rosti G; Chauvin F
    Eur J Cancer; 1997 Oct; 33(12):2130-5. PubMed ID: 9516868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects in survivors of high-risk neuroblastoma following stem cell transplant with and without total body irradiation.
    Hobbie WL; Li Y; Carlson C; Goldfarb S; Laskin B; Denburg M; Goldmuntz E; Mostoufi-Moab S; Wilkes J; Smith K; Sacks N; Szalda D; Ginsberg JP
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29537. PubMed ID: 34971017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
    Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian function in female survivors of high-risk neuroblastoma.
    Jimenez-Kurlander L; DeRosa A; Kostrzewa CE; Moskowitz CS; Bogardus K; Antal Z; Wolden S; La Quaglia MP; Basu EM; Cardenas FI; Kramer K; Kushner BH; Cheung NV; Modak S; Friedman DN
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31181. PubMed ID: 38967225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine consequences of neuroblastoma treatment in children: 20 years' experience of a single center.
    Geurten C; Geurten M; Hoyoux C; Lebrethon MC
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):347-354. PubMed ID: 30875326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma.
    Hobbie WL; Moshang T; Carlson CA; Goldmuntz E; Sacks N; Goldfarb SB; Grupp SA; Ginsberg JP
    Pediatr Blood Cancer; 2008 Nov; 51(5):679-83. PubMed ID: 18623215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.
    Desai AV; Heneghan MB; Li Y; Bunin NJ; Grupp SA; Bagatell R; Seif AE
    Bone Marrow Transplant; 2016 Sep; 51(9):1204-10. PubMed ID: 27159174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.